ATE140228T1 - Hydroxymethyl-indolizidine und -chinolizidine - Google Patents

Hydroxymethyl-indolizidine und -chinolizidine

Info

Publication number
ATE140228T1
ATE140228T1 AT91105014T AT91105014T ATE140228T1 AT E140228 T1 ATE140228 T1 AT E140228T1 AT 91105014 T AT91105014 T AT 91105014T AT 91105014 T AT91105014 T AT 91105014T AT E140228 T1 ATE140228 T1 AT E140228T1
Authority
AT
Austria
Prior art keywords
indolizidines
quinolicidines
hydroxymethyl
compounds
quinolizidines
Prior art date
Application number
AT91105014T
Other languages
English (en)
Inventor
Paul S Liu
Roland S Rogers
Mohinder S Kang
Barry L Rhinehart
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE140228T1 publication Critical patent/ATE140228T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT91105014T 1990-03-30 1991-03-28 Hydroxymethyl-indolizidine und -chinolizidine ATE140228T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/502,602 US5028614A (en) 1990-03-30 1990-03-30 Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors

Publications (1)

Publication Number Publication Date
ATE140228T1 true ATE140228T1 (de) 1996-07-15

Family

ID=23998556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105014T ATE140228T1 (de) 1990-03-30 1991-03-28 Hydroxymethyl-indolizidine und -chinolizidine

Country Status (18)

Country Link
US (1) US5028614A (de)
EP (1) EP0449294B1 (de)
JP (1) JP3019270B2 (de)
KR (1) KR100195422B1 (de)
CN (1) CN1055362A (de)
AT (1) ATE140228T1 (de)
AU (1) AU638318B2 (de)
CA (1) CA2038984C (de)
DE (1) DE69120705T2 (de)
ES (1) ES2093040T3 (de)
FI (1) FI911510A (de)
HU (1) HU208974B (de)
IE (1) IE911063A1 (de)
IL (1) IL97698A0 (de)
NO (1) NO911237L (de)
NZ (1) NZ237567A (de)
PT (1) PT97201A (de)
ZA (1) ZA912236B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152054A (en) * 1990-05-25 1992-10-06 Seiko Epson Corporation Method of making film carrier structure for integrated circuit tape automated bonding
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
JPH07502724A (ja) * 1991-08-09 1995-03-23 ニコムド　イノベーション　アーベー 磁気共鳴造影における持続性フリーラジカルの使用
EP0738498A1 (de) * 1995-04-18 1996-10-23 Machida Endoscope Co., Ltd Chirurgische Klebestoffspritzvorrichtung
US7285667B2 (en) * 2005-04-26 2007-10-23 Wyeth Process for the synthesis of functionalized indolizidines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235878A3 (de) * 1986-01-16 1989-06-14 Beecham Group Plc Neue Verbindungen
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
EP0449294B1 (de) 1996-07-10
NO911237L (no) 1991-10-01
HUT57209A (en) 1991-11-28
FI911510A (fi) 1991-10-01
ES2093040T3 (es) 1996-12-16
NO911237D0 (no) 1991-03-26
CA2038984C (en) 2002-12-24
FI911510A0 (fi) 1991-03-27
HU208974B (en) 1994-02-28
DE69120705T2 (de) 1996-11-07
CA2038984A1 (en) 1991-10-01
ZA912236B (en) 1991-12-24
EP0449294A1 (de) 1991-10-02
CN1055362A (zh) 1991-10-16
US5028614A (en) 1991-07-02
PT97201A (pt) 1991-11-29
NZ237567A (en) 1994-12-22
DE69120705D1 (de) 1996-08-14
JPH04221382A (ja) 1992-08-11
IE911063A1 (en) 1991-10-09
AU7381991A (en) 1991-10-03
AU638318B2 (en) 1993-06-24
JP3019270B2 (ja) 2000-03-13
IL97698A0 (en) 1992-06-21
HU911039D0 (en) 1991-10-28
KR100195422B1 (ko) 1999-06-15
KR910016750A (ko) 1991-11-05

Similar Documents

Publication Publication Date Title
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DE19975006I2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler St¦rungen.
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
ATE140228T1 (de) Hydroxymethyl-indolizidine und -chinolizidine
WO1996031208A3 (de) Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten
DK0444482T3 (da) Oxetanoner
EP0420116A3 (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
PT87704A (pt) Process for preparing pharmaceutical compositions for transdermal delivery containing a 1,4-dihydropyride derivative
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
ZA915660B (en) Novel substituted piperidines and their use as inhibitors of cholesterol synthesis
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69221649T2 (de) Lacidipin zur Behandlung der Arteriosklerosis
NO881798L (no) Fremgangsmaate for fremstilling av et antiastmapreparat.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee